Share Price and Basic Stock Data
Last Updated: February 12, 2026, 8:58 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kothari Sugars & Chemicals Ltd operates within the sugar industry and has reported revenue figures reflecting a fluctuating performance over recent quarters. The company’s sales stood at ₹609 Cr for the financial year ending March 2023, a notable increase from ₹422 Cr in the previous year. However, subsequent quarterly sales have shown volatility, with ₹207 Cr in March 2023 declining to ₹113 Cr by September 2023, and a modest recovery to ₹132 Cr in December 2023. Over the trailing twelve months (TTM), the sales have declined to ₹254 Cr. This inconsistency in revenue generation raises concerns about the company’s ability to maintain stable operational performance amidst challenging market conditions. Furthermore, the operating profit margin (OPM) has been negative at -9%, indicating significant cost pressures relative to sales. The recent quarterly figures highlight a need for Kothari Sugars to improve efficiency and stabilize its revenue streams to enhance overall business resilience.
Profitability and Efficiency Metrics
Kothari Sugars has faced significant challenges regarding profitability, as evidenced by the reported net profit figures. The company recorded a net profit of ₹42 Cr for the year ending March 2023, but this sharply contrasted with a decline to ₹10 Cr for March 2025, reflecting ongoing operational difficulties. The operating profit has shown a similar trend, peaking at ₹61 Cr in March 2023 before dropping to just ₹12 Cr in March 2025. The return on equity (ROE) stood at 1.69%, while the return on capital employed (ROCE) was reported at 3.22%, both of which are significantly below industry averages, indicating inefficiencies in capital utilization. Additionally, the cash conversion cycle (CCC) of 71 days suggests prolonged inventory and receivables management, which could further strain liquidity. The company’s ability to address these profitability and efficiency issues will be crucial for future sustainability and growth.
Balance Sheet Strength and Financial Ratios
Kothari Sugars demonstrates a mixed financial position, with total borrowings reported at ₹49 Cr against reserves of ₹200 Cr, indicating a manageable debt level relative to equity. The interest coverage ratio (ICR) stands at 5.08x, suggesting the company can cover its interest obligations comfortably, which is a positive sign for creditors and investors. However, the price-to-book value (P/BV) ratio is notably low at 0.11x, reflecting market skepticism regarding the company’s growth prospects relative to its book value. The total liabilities have increased to ₹419 Cr, while total assets stood at ₹419 Cr, indicating a balanced structure but raising questions about asset utilization efficiency. The balance sheet reflects both strengths in terms of manageable debt levels and weaknesses in profitability metrics, necessitating a focused strategy to enhance operational performance and restore investor confidence.
Shareholding Pattern and Investor Confidence
The shareholding structure of Kothari Sugars shows a predominant promoter holding of 73.53%, which indicates strong control by the founding family. However, foreign institutional investors (FIIs) have reduced their stake to 0.22% from 0.74% over the past year, suggesting declining confidence among international investors. Domestic institutional investors (DIIs) hold a modest 0.63%, reflecting limited interest from institutional players. The public shareholding has remained relatively stable at 25.61%, with the total number of shareholders reported at 68,598. This concentration of ownership among promoters coupled with low institutional participation may hinder liquidity and market perception. The reduction in FIIs’ stake could be a signal of caution regarding the company’s future performance, and addressing investor concerns will be vital for Kothari Sugars to attract broader market interest.
Outlook, Risks, and Final Insight
Looking ahead, Kothari Sugars faces several risks that could impact its operational and financial stability. The volatility in revenue and profitability poses significant challenges, as does the company’s reliance on the sugar market, which is subject to fluctuations in global prices and domestic production levels. Additionally, rising operational costs may further compress margins if not managed effectively. Strengths include a manageable debt profile and significant reserves that provide a cushion against market downturns. The company’s ability to enhance operational efficiency and stabilize revenues will be critical for its long-term sustainability. In a scenario where Kothari Sugars successfully implements cost-control measures and improves its sales performance, it could regain investor confidence and enhance profitability. Conversely, continued operational challenges without strategic interventions could lead to further declines, impacting its viability in the competitive sugar industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 74.2 Cr. | 9.98 | 16.7/7.02 | 16.8 | 0.00 % | 36.6 % | % | 10.0 | |
| Dhampure Speciality Sugars Ltd | 92.5 Cr. | 106 | 115/82.0 | 17.6 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 668 Cr. | 100 | 115/57.3 | 28.2 | 145 | 1.24 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 514 Cr. | 39.3 | 63.1/36.0 | 8.43 | 105 | 5.09 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 646 Cr. | 4.50 | 10.3/3.03 | 76.1 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,799.62 Cr | 254.59 | 21.23 | 225.56 | 0.84% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 128 | 207 | 163 | 113 | 132 | 94 | 90 | 102 | 83 | 36 | 67 | 68 | 70 |
| Expenses | 136 | 179 | 133 | 101 | 133 | 91 | 89 | 91 | 79 | 39 | 66 | 76 | 76 |
| Operating Profit | -8 | 29 | 30 | 12 | -0 | 3 | 1 | 11 | 3 | -3 | 1 | -8 | -6 |
| OPM % | -6% | 14% | 18% | 10% | -0% | 3% | 1% | 10% | 4% | -8% | 2% | -12% | -9% |
| Other Income | 2 | 6 | 3 | 4 | 4 | 5 | 4 | 4 | 9 | 6 | 6 | 2 | 22 |
| Interest | 1 | 0 | 1 | 1 | 0 | 1 | 2 | 1 | 0 | 1 | 2 | 1 | 1 |
| Depreciation | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | -10 | 31 | 28 | 11 | -0 | 4 | -1 | 10 | 9 | -1 | 2 | -11 | 12 |
| Tax % | -28% | 22% | 35% | 51% | -3,850% | -49% | -35% | 36% | 39% | -32% | 24% | -33% | 1% |
| Net Profit | -7 | 24 | 18 | 5 | 1 | 6 | -1 | 6 | 5 | -1 | 1 | -7 | 12 |
| EPS in Rs | -0.88 | 2.86 | 2.16 | 0.62 | 0.09 | 0.68 | -0.06 | 0.75 | 0.65 | -0.08 | 0.15 | -0.87 | 1.44 |
Last Updated: February 5, 2026, 6:16 am
Below is a detailed analysis of the quarterly data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Sep 2025) to 70.00 Cr., marking an increase of 2.00 Cr..
- For Expenses, as of Dec 2025, the value is 76.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 76.00 Cr..
- For Operating Profit, as of Dec 2025, the value is -6.00 Cr.. The value appears strong and on an upward trend. It has increased from -8.00 Cr. (Sep 2025) to -6.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Dec 2025, the value is -9.00%. The value appears strong and on an upward trend. It has increased from -12.00% (Sep 2025) to -9.00%, marking an increase of 3.00%.
- For Other Income, as of Dec 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Sep 2025) to 22.00 Cr., marking an increase of 20.00 Cr..
- For Interest, as of Dec 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 1.00 Cr..
- For Depreciation, as of Dec 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from -11.00 Cr. (Sep 2025) to 12.00 Cr., marking an increase of 23.00 Cr..
- For Tax %, as of Dec 2025, the value is 1.00%. The value appears to be increasing, which may not be favorable. It has increased from -33.00% (Sep 2025) to 1.00%, marking an increase of 34.00%.
- For Net Profit, as of Dec 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from -7.00 Cr. (Sep 2025) to 12.00 Cr., marking an increase of 19.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 1.44. The value appears strong and on an upward trend. It has increased from -0.87 (Sep 2025) to 1.44, marking an increase of 2.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:05 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 323 | 340 | 247 | 317 | 287 | 332 | 352 | 419 | 422 | 609 | 503 | 310 | 254 |
| Expenses | 302 | 331 | 229 | 280 | 259 | 309 | 324 | 386 | 373 | 548 | 458 | 298 | 260 |
| Operating Profit | 21 | 9 | 18 | 36 | 28 | 23 | 28 | 33 | 50 | 61 | 44 | 12 | -6 |
| OPM % | 7% | 3% | 7% | 11% | 10% | 7% | 8% | 8% | 12% | 10% | 9% | 4% | -2% |
| Other Income | 9 | 11 | 7 | -1 | -5 | 20 | 11 | 10 | 8 | 12 | 15 | 23 | 23 |
| Interest | 10 | 5 | 7 | 8 | 6 | 7 | 7 | 5 | 4 | 4 | 4 | 4 | 4 |
| Depreciation | 16 | 16 | 15 | 15 | 14 | 13 | 13 | 14 | 14 | 14 | 14 | 15 | 15 |
| Profit before tax | 5 | -0 | 3 | 13 | 3 | 23 | 19 | 23 | 39 | 55 | 42 | 17 | -1 |
| Tax % | 39% | 1,200% | 58% | 17% | 82% | 44% | -2% | 19% | 14% | 24% | 30% | 38% | |
| Net Profit | 3 | -5 | 1 | 10 | 0 | 13 | 19 | 19 | 34 | 42 | 29 | 10 | -1 |
| EPS in Rs | 0.34 | -0.55 | 0.14 | 1.26 | 0.06 | 1.53 | 2.34 | 2.29 | 4.11 | 5.06 | 3.56 | 1.26 | -0.15 |
| Dividend Payout % | 149% | 0% | 0% | 40% | 0% | 33% | 0% | 0% | 0% | 20% | 14% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -266.67% | 120.00% | 900.00% | -100.00% | 46.15% | 0.00% | 78.95% | 23.53% | -30.95% | -65.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | 386.67% | 780.00% | -1000.00% | 146.15% | -46.15% | 78.95% | -55.42% | -54.48% | -34.56% |
Kothari Sugars & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -3% |
| 3 Years: | -10% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -20% |
| 3 Years: | -47% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | -10% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 9:20 am
Balance Sheet
Last Updated: January 7, 2026, 3:58 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 |
| Reserves | 38 | 34 | 35 | 49 | 56 | 69 | 84 | 103 | 137 | 175 | 196 | 206 | 200 |
| Borrowings | 144 | 166 | 175 | 146 | 120 | 116 | 84 | 36 | 57 | 38 | 70 | 50 | 49 |
| Other Liabilities | 110 | 75 | 76 | 103 | 110 | 123 | 124 | 119 | 118 | 137 | 135 | 111 | 87 |
| Total Liabilities | 375 | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 419 |
| Fixed Assets | 219 | 209 | 195 | 191 | 178 | 167 | 172 | 162 | 153 | 152 | 164 | 150 | 150 |
| CWIP | 6 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 9 | 0 | 4 | 10 |
| Investments | 16 | 18 | 18 | 20 | 33 | 48 | 30 | 58 | 71 | 72 | 100 | 133 | 116 |
| Other Assets | 135 | 131 | 155 | 169 | 159 | 174 | 172 | 121 | 170 | 200 | 219 | 162 | 143 |
| Total Assets | 375 | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 419 |
Below is a detailed analysis of the balance sheet data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 83.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 83.00 Cr..
- For Reserves, as of Sep 2025, the value is 200.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Mar 2025) to 200.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 49.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 50.00 Cr. (Mar 2025) to 49.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 111.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 24.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 419.00 Cr.. The value appears to be improving (decreasing). It has decreased from 451.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 32.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 150.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 150.00 Cr..
- For CWIP, as of Sep 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 6.00 Cr..
- For Investments, as of Sep 2025, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 133.00 Cr. (Mar 2025) to 116.00 Cr., marking a decrease of 17.00 Cr..
- For Other Assets, as of Sep 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 162.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 19.00 Cr..
- For Total Assets, as of Sep 2025, the value is 419.00 Cr.. The value appears to be declining and may need further review. It has decreased from 451.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 32.00 Cr..
Notably, the Reserves (200.00 Cr.) exceed the Borrowings (49.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -123.00 | -157.00 | -157.00 | -110.00 | -92.00 | -93.00 | -56.00 | -3.00 | -7.00 | 23.00 | -26.00 | -38.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 9 | 14 | 16 | 23 | 19 | 28 | 18 | 21 | 17 | 16 | 20 |
| Inventory Days | 152 | 139 | 236 | 235 | 224 | 216 | 181 | 101 | 165 | 117 | 180 | 161 |
| Days Payable | 72 | 45 | 60 | 88 | 133 | 127 | 111 | 95 | 99 | 73 | 93 | 110 |
| Cash Conversion Cycle | 95 | 103 | 189 | 162 | 114 | 108 | 99 | 24 | 88 | 61 | 103 | 71 |
| Working Capital Days | 30 | 20 | 8 | 0 | -17 | -10 | -1 | 2 | 16 | 24 | 30 | 36 |
| ROCE % | 5% | 1% | 3% | 9% | 7% | 10% | 8% | 10% | 17% | 18% | 14% | 3% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.28 | 1.44 | 0.37 | -0.26 | 0.43 |
| Diluted EPS (Rs.) | 0.28 | 1.44 | 0.37 | -0.26 | 0.43 |
| Cash EPS (Rs.) | 1.71 | 3.06 | 1.91 | 1.39 | 2.18 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.85 | 17.41 | 15.66 | 15.52 | 16.06 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.85 | 17.41 | 15.66 | 15.52 | 16.06 |
| Revenue From Operations / Share (Rs.) | 34.62 | 38.21 | 29.75 | 41.02 | 39.02 |
| PBDIT / Share (Rs.) | 3.98 | 5.05 | 2.97 | 2.52 | 3.64 |
| PBIT / Share (Rs.) | 2.31 | 3.29 | 1.20 | 0.59 | 1.70 |
| PBT / Share (Rs.) | 0.30 | 1.56 | 0.34 | -0.02 | 0.49 |
| Net Profit / Share (Rs.) | 0.04 | 1.30 | 0.13 | -0.53 | 0.23 |
| NP After MI And SOA / Share (Rs.) | 0.27 | 1.44 | 0.36 | -0.26 | 0.43 |
| PBDIT Margin (%) | 11.50 | 13.22 | 9.97 | 6.14 | 9.32 |
| PBIT Margin (%) | 6.67 | 8.60 | 4.03 | 1.44 | 4.35 |
| PBT Margin (%) | 0.86 | 4.08 | 1.16 | -0.05 | 1.27 |
| Net Profit Margin (%) | 0.11 | 3.39 | 0.46 | -1.31 | 0.61 |
| NP After MI And SOA Margin (%) | 0.79 | 3.77 | 1.23 | -0.63 | 1.11 |
| Return on Networth / Equity (%) | 1.64 | 8.28 | 2.33 | -1.68 | 2.70 |
| Return on Capital Employeed (%) | 9.11 | 11.54 | 3.90 | 1.80 | 4.85 |
| Return On Assets (%) | 0.60 | 2.98 | 0.79 | -0.58 | 0.92 |
| Long Term Debt / Equity (X) | 0.25 | 0.37 | 0.71 | 0.83 | 0.86 |
| Total Debt / Equity (X) | 0.73 | 0.78 | 1.06 | 1.16 | 0.89 |
| Asset Turnover Ratio (%) | 0.73 | 0.82 | 0.66 | 0.91 | 0.83 |
| Current Ratio (X) | 1.07 | 1.14 | 1.33 | 1.46 | 1.46 |
| Quick Ratio (X) | 0.29 | 0.26 | 0.40 | 0.45 | 0.40 |
| Inventory Turnover Ratio (X) | 1.47 | 1.92 | 1.83 | 2.58 | 2.51 |
| Dividend Payout Ratio (NP) (%) | 217.73 | 0.00 | 0.00 | 0.00 | 115.05 |
| Dividend Payout Ratio (CP) (%) | 30.89 | 0.00 | 0.00 | 0.00 | 21.03 |
| Earning Retention Ratio (%) | -117.73 | 0.00 | 0.00 | 0.00 | -15.05 |
| Cash Earning Retention Ratio (%) | 69.11 | 0.00 | 0.00 | 0.00 | 78.97 |
| Interest Coverage Ratio (X) | 5.08 | 5.16 | 3.47 | 4.11 | 3.03 |
| Interest Coverage Ratio (Post Tax) (X) | 2.62 | 3.09 | 1.16 | 0.12 | 1.20 |
| Enterprise Value (Cr.) | 116.17 | 126.76 | 138.08 | 160.99 | 139.15 |
| EV / Net Operating Revenue (X) | 0.40 | 0.40 | 0.55 | 0.47 | 0.43 |
| EV / EBITDA (X) | 3.52 | 3.03 | 5.61 | 7.71 | 4.61 |
| MarketCap / Net Operating Revenue (X) | 0.05 | 0.05 | 0.06 | 0.04 | 0.05 |
| Retention Ratios (%) | -117.73 | 0.00 | 0.00 | 0.00 | -15.05 |
| Price / BV (X) | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 |
| Price / Net Operating Revenue (X) | 0.05 | 0.05 | 0.06 | 0.04 | 0.05 |
| EarningsYield | 0.13 | 0.72 | 0.18 | -0.13 | 0.21 |
After reviewing the key financial ratios for Kothari Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
- For Diluted EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
- For Cash EPS (Rs.), as of Mar 18, the value is 1.71. This value is below the healthy minimum of 3. It has decreased from 3.06 (Mar 17) to 1.71, marking a decrease of 1.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 34.62. It has decreased from 38.21 (Mar 17) to 34.62, marking a decrease of 3.59.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 3.98. This value is within the healthy range. It has decreased from 5.05 (Mar 17) to 3.98, marking a decrease of 1.07.
- For PBIT / Share (Rs.), as of Mar 18, the value is 2.31. This value is within the healthy range. It has decreased from 3.29 (Mar 17) to 2.31, marking a decrease of 0.98.
- For PBT / Share (Rs.), as of Mar 18, the value is 0.30. This value is within the healthy range. It has decreased from 1.56 (Mar 17) to 0.30, marking a decrease of 1.26.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 1.30 (Mar 17) to 0.04, marking a decrease of 1.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 0.27. This value is below the healthy minimum of 2. It has decreased from 1.44 (Mar 17) to 0.27, marking a decrease of 1.17.
- For PBDIT Margin (%), as of Mar 18, the value is 11.50. This value is within the healthy range. It has decreased from 13.22 (Mar 17) to 11.50, marking a decrease of 1.72.
- For PBIT Margin (%), as of Mar 18, the value is 6.67. This value is below the healthy minimum of 10. It has decreased from 8.60 (Mar 17) to 6.67, marking a decrease of 1.93.
- For PBT Margin (%), as of Mar 18, the value is 0.86. This value is below the healthy minimum of 10. It has decreased from 4.08 (Mar 17) to 0.86, marking a decrease of 3.22.
- For Net Profit Margin (%), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 3.39 (Mar 17) to 0.11, marking a decrease of 3.28.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 0.79. This value is below the healthy minimum of 8. It has decreased from 3.77 (Mar 17) to 0.79, marking a decrease of 2.98.
- For Return on Networth / Equity (%), as of Mar 18, the value is 1.64. This value is below the healthy minimum of 15. It has decreased from 8.28 (Mar 17) to 1.64, marking a decrease of 6.64.
- For Return on Capital Employeed (%), as of Mar 18, the value is 9.11. This value is below the healthy minimum of 10. It has decreased from 11.54 (Mar 17) to 9.11, marking a decrease of 2.43.
- For Return On Assets (%), as of Mar 18, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 2.98 (Mar 17) to 0.60, marking a decrease of 2.38.
- For Long Term Debt / Equity (X), as of Mar 18, the value is 0.25. This value is within the healthy range. It has decreased from 0.37 (Mar 17) to 0.25, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.73. This value is within the healthy range. It has decreased from 0.78 (Mar 17) to 0.73, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.73. It has decreased from 0.82 (Mar 17) to 0.73, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 18, the value is 1.07. This value is below the healthy minimum of 1.5. It has decreased from 1.14 (Mar 17) to 1.07, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 18, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 17) to 0.29, marking an increase of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 1.47. This value is below the healthy minimum of 4. It has decreased from 1.92 (Mar 17) to 1.47, marking a decrease of 0.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 18, the value is 217.73. This value exceeds the healthy maximum of 50. It has increased from 0.00 (Mar 17) to 217.73, marking an increase of 217.73.
- For Dividend Payout Ratio (CP) (%), as of Mar 18, the value is 30.89. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 30.89, marking an increase of 30.89.
- For Earning Retention Ratio (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 40. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
- For Cash Earning Retention Ratio (%), as of Mar 18, the value is 69.11. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 69.11, marking an increase of 69.11.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 5.08. This value is within the healthy range. It has decreased from 5.16 (Mar 17) to 5.08, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 2.62. This value is below the healthy minimum of 3. It has decreased from 3.09 (Mar 17) to 2.62, marking a decrease of 0.47.
- For Enterprise Value (Cr.), as of Mar 18, the value is 116.17. It has decreased from 126.76 (Mar 17) to 116.17, marking a decrease of 10.59.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.40. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.40.
- For EV / EBITDA (X), as of Mar 18, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 3.03 (Mar 17) to 3.52, marking an increase of 0.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
- For Retention Ratios (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 30. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
- For Price / BV (X), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.11.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
- For EarningsYield, as of Mar 18, the value is 0.13. This value is below the healthy minimum of 5. It has decreased from 0.72 (Mar 17) to 0.13, marking a decrease of 0.59.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kothari Sugars & Chemicals Ltd:
- Net Profit Margin: 0.11%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.11% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.64% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.29
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 21.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.73
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.11%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | Kothari Buildings, No.115, Mahatma Gandhi Salai, Chennai (Madras) Tamil Nadu 600034 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Nina B Kothari | Chairperson & Non Executive Director |
| Mr. Arjun B Kothari | Managing Director |
| Mr. M Silvester Goldwin | Whole Time Director |
| Mr. Abdul Kareem Sait | Independent Director |
| Mr. M R Mohan | Independent Director |
| Mr. S Sundarraman | Independent Director |
FAQ
What is the intrinsic value of Kothari Sugars & Chemicals Ltd?
Kothari Sugars & Chemicals Ltd's intrinsic value (as of 12 February 2026) is ₹5.07 which is 81.08% lower the current market price of ₹26.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹222 Cr. market cap, FY2025-2026 high/low of ₹41.4/23.5, reserves of ₹200 Cr, and liabilities of ₹419 Cr.
What is the Market Cap of Kothari Sugars & Chemicals Ltd?
The Market Cap of Kothari Sugars & Chemicals Ltd is 222 Cr..
What is the current Stock Price of Kothari Sugars & Chemicals Ltd as on 12 February 2026?
The current stock price of Kothari Sugars & Chemicals Ltd as on 12 February 2026 is ₹26.8.
What is the High / Low of Kothari Sugars & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kothari Sugars & Chemicals Ltd stocks is ₹41.4/23.5.
What is the Stock P/E of Kothari Sugars & Chemicals Ltd?
The Stock P/E of Kothari Sugars & Chemicals Ltd is .
What is the Book Value of Kothari Sugars & Chemicals Ltd?
The Book Value of Kothari Sugars & Chemicals Ltd is 34.2.
What is the Dividend Yield of Kothari Sugars & Chemicals Ltd?
The Dividend Yield of Kothari Sugars & Chemicals Ltd is 0.00 %.
What is the ROCE of Kothari Sugars & Chemicals Ltd?
The ROCE of Kothari Sugars & Chemicals Ltd is 3.22 %.
What is the ROE of Kothari Sugars & Chemicals Ltd?
The ROE of Kothari Sugars & Chemicals Ltd is 1.69 %.
What is the Face Value of Kothari Sugars & Chemicals Ltd?
The Face Value of Kothari Sugars & Chemicals Ltd is 10.0.